Global Longlife Hospital And Research Ltd vs Nephro Care India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Global Longlife Hospital and Research Ltd is ₹ 12.57 as of 23 Oct 15:30 . The P/E Ratio of Global Longlife Hospital and Research Ltd is 0 as of March 2026 .The P/E Ratio of Nephro Care India Ltd is 25.4 as of March 2026 . The Market Cap of Global Longlife Hospital and Research Ltd is ₹ 0 crore as of March 2026 .The Market Cap of Nephro Care India Ltd is ₹ 85.32 crore as of March 2026 . The Revenue of Global Longlife Hospital and Research Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Nephro Care India Ltd is ₹ 17.39 crore as of Jun '25 . The EBITDA of Global Longlife Hospital and Research Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Nephro Care India Ltd is ₹ 0.66 crore as of Jun '25 . The Net Profit of Global Longlife Hospital and Research Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Nephro Care India Ltd is ₹ -0.65 crore as of Jun '25 . The Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Nephro Care India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution in Ahmedabad.
Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

About Nephro Care India Ltd

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal.
Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients.
The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

FAQs for the comparison of Global Longlife Hospital and Research Ltd and Nephro Care India Ltd

Which company has a larger market capitalization, Global Longlife Hospital and Research Ltd or Nephro Care India Ltd?

Market cap of Global Longlife Hospital and Research Ltd is 13 Cr while Market cap of Nephro Care India Ltd is 136 Cr

What are the key factors driving the stock performance of Global Longlife Hospital and Research Ltd and Nephro Care India Ltd?

The stock performance of Global Longlife Hospital and Research Ltd and Nephro Care India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Global Longlife Hospital and Research Ltd and Nephro Care India Ltd?

As of October 25, 2026, the Global Longlife Hospital and Research Ltd stock price is INR ₹12.57. On the other hand, Nephro Care India Ltd stock price is INR ₹83.0.

How do dividend payouts of Global Longlife Hospital and Research Ltd and Nephro Care India Ltd compare?

To compare the dividend payouts of Global Longlife Hospital and Research Ltd and Nephro Care India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.